These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 24484460)

  • 21. Implementation of a structured guideline-based program for the secondary prevention of ischemic stroke in China.
    Peng B; Ni J; Anderson CS; Zhu Y; Wang Y; Pu C; Wu J; Wang J; Zhou L; Yao M; He J; Shan G; Gao S; Xu W; Cui L;
    Stroke; 2014 Feb; 45(2):515-9. PubMed ID: 24385269
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Should I start all my ischaemic stroke and TIA patients on a statin, an ACE inhibitor, a diuretic, and aspirin today?
    Sandercock PA
    J Neurol Neurosurg Psychiatry; 2003 Nov; 74(11):1461-4. PubMed ID: 14617697
    [No Abstract]   [Full Text] [Related]  

  • 23. Statintherapy in the primary and the secondary prevention of ischaemic cerebrovascular diseases.
    Feher A; Pusch G; Koltai K; Tibold A; Gasztonyi B; Szapary L; Feher G
    Int J Cardiol; 2011 Apr; 148(2):131-8. PubMed ID: 20843571
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Neurological characteristics of the ischemic stroke course in patients with atrial fibrillation].
    Murashko NK; Shkliaieva OP
    Lik Sprava; 2013; (1):77-82. PubMed ID: 23951914
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Warfarin or aspirin for recurrent ischemic stroke.
    Algra A;
    N Engl J Med; 2002 Apr; 346(15):1169-71. PubMed ID: 11951857
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of prestroke use of angiotensin-converting enzyme inhibitors alone versus combination with antiplatelets and statin on ischemic stroke outcome.
    Hassan Y; Al-Jabi SW; Aziz NA; Looi I; Zyoud SH
    Clin Neuropharmacol; 2011; 34(6):234-40. PubMed ID: 21996648
    [TBL] [Abstract][Full Text] [Related]  

  • 27. From head to toe: Sex and gender differences in the treatment of ischemic cerebral disease.
    Falsetti L; Viticchi G; Buratti L; Balucani C; Marra AM; Silvestrini M
    Pharmacol Res; 2017 Jul; 121():240-250. PubMed ID: 28506796
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Letter by Meves and Neubauer regarding article "Clinical outcomes using a platelet function-guided approach for secondary prevention in patients with ischemic stroke or transient ischemic attack".
    Meves SH; Neubauer H
    Stroke; 2012 Nov; 43(11):e167; author reply e168. PubMed ID: 23091124
    [No Abstract]   [Full Text] [Related]  

  • 29. Lipid-lowering drugs in ischemic stroke prevention and their influence on acute stroke outcome.
    Fuentes B; Martínez-Sánchez P; Díez-Tejedor E
    Cerebrovasc Dis; 2009; 27 Suppl 1():126-33. PubMed ID: 19342842
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Secondary prevention in patients with ischemic stroke: it is time to act].
    Castilla Guerra L; Fernández Moreno MC
    Rev Clin Esp; 2008 May; 208(5):209-10. PubMed ID: 18457629
    [No Abstract]   [Full Text] [Related]  

  • 31. Outcome of ischemic stroke in older adults.
    Shil AB
    J Am Geriatr Soc; 2010 Jun; 58(6):1203-4. PubMed ID: 20722859
    [No Abstract]   [Full Text] [Related]  

  • 32. Oral Anticoagulation in Very Elderly Patients With Atrial Fibrillation: A Nationwide Cohort Study.
    Chao TF; Liu CJ; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Liao JN; Chung FP; Chen TJ; Lip GYH; Chen SA
    Circulation; 2018 Jul; 138(1):37-47. PubMed ID: 29490992
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Statin medications may improve stroke outcomes, recovery.
    Mayo Clin Womens Healthsource; 2009 Aug; 13(8):3. PubMed ID: 19584800
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical outcomes using a platelet function-guided approach for secondary prevention in patients with ischemic stroke or transient ischemic attack.
    Depta JP; Fowler J; Novak E; Katzan I; Bakdash S; Kottke-Marchant K; Bhatt DL
    Stroke; 2012 Sep; 43(9):2376-81. PubMed ID: 22713488
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Secondary prevention of ischaemic stroke and TIA.
    Diener HC
    Cardiovasc J Afr; 2008; 19(4):229. PubMed ID: 18776974
    [No Abstract]   [Full Text] [Related]  

  • 36. Rosuvastatin may stabilize atherosclerotic aortic plaque: transesophageal echocardiographic study in the EPISTEME trial.
    Ueno Y; Yamashiro K; Tanaka Y; Watanabe M; Miyamoto N; Shimada Y; Kuroki T; Tanaka R; Miyauchi K; Daida H; Hattori N; Urabe T
    Atherosclerosis; 2015 Apr; 239(2):476-82. PubMed ID: 25702618
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Do we need to assess the effect of treatment withdrawal? The paradigm of life-long prevention.
    Gueyffier F; Bejan-Angoulvant T
    Stroke; 2007 Oct; 38(10):2629-30. PubMed ID: 17761906
    [No Abstract]   [Full Text] [Related]  

  • 38. The ideal antiplatelet drug for stroke prevention--still elusive.
    Norris JW
    Stroke; 2008 Apr; 39(4):1076-7. PubMed ID: 18323472
    [No Abstract]   [Full Text] [Related]  

  • 39. [Important aim of statin therapy: ischemic cardiovascular event (stroke)].
    Császár A
    Ideggyogy Sz; 2008 Jul; 61(7-8):239-43. PubMed ID: 18763479
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-platelet or anti-coagulant agent for prevention of ischemic stroke in patients with end-stage renal disease and atrial fibrillation, is it necessary?
    Chen JJ; Lin LY; Yang YH; Hwang JJ; Chen PC; Lin JL
    Int J Cardiol; 2015 Oct; 196():53. PubMed ID: 26073213
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.